N/A
N=138
Safety of Treatment of Shoulder Repair
Rotator Cuff
Bottom Line
View on ClinicalTrials.gov: NCT04552119 ↗Enrolled (actual)
138
Serious AEs
14.5%
Results posted
Apr 2026
Primary outcome: Primary: Clinical Success Rate at 6 Months — 58; 68 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- HEALICOIL Knotless PEEK (Device); HEALICOIL Knotless REGENESORB (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Smith & Nephew, Inc.
- Primary completion
- May 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinical Success Rate at 6 Months |
58; 68 | — |
| SECONDARY Clinical Success Rate at 12 Months |
51; 63 | — |
| SECONDARY Clinical Success Rate at 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping Suture Anchor ONLY) |
27 | — |
| SECONDARY Constant-Murley Score |
48.02; 44.93; 73.58; 67.94; 79.43; 74.40 | — |
| SECONDARY American Shoulder and Elbow Surgeons (ASES) Score |
49.83; 46.13; 85.45; 83.79; 93.14; 89.63 | — |
| SECONDARY American Shoulder and Elbow Surgeons (ASES): Visual Analog Scale (VAS) Pain Score |
5.24; 5.94; 1.73; 1.79; 0.90; 1.34 | — |
| SECONDARY Single Assessment Numeric Evaluation (SANE) Shoulder Scale at 6 Months and 12 Months |
48.93; 45.59; 86.71; 86.31; 94.22; 93.03 | — |
| SECONDARY EuroQol (European Quality of Life) Five-dimensional Three-level (EQ-5D-3L): Index Score |
0.82; 0.81; 0.93; 0.91; 0.95; 0.94 | — |
| SECONDARY EuroQol (European Quality of Life) Five-dimensional Three-level (EQ-5D-3L): Visual Analogue Scale (VAS) Score |
76.81; 71.78; 86.06; 81.82; 84.65; 83.77 | — |
| SECONDARY Tendon Thickening at 6 Months and 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping ONLY) |
6.5; 6.3; 6.6; 6.0; 5.5; 6.1 | — |
| SECONDARY Tendon Re-tear Status at 6 Months and 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping ONLY) |
25; 5; 17; 5 | — |
Summary
This study evaluates the safety of the HEALICOIL Knotless Suture Anchors in patients requiring a repair of the rotator cuff tendon repair
Eligibility Criteria
Inclusion Criteria
- Requires reattachment of soft tissue to bone for the following shoulder indications:
- Rotator Cuff Tendon repair:
- i. Single or double row rotator cuff repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping; OR
- ii. Double row rotator cuff repair using HEALICOIL Knotless RG NST in lateral row (existing HEALICOIL RG device to be used in medial row of the repair); AND/OR
- Biceps tenodesis
- i. In conjunction with Rotator Cuff Tendon repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, HEALICOIL Knotless RG NST or HEALICOIL Knotless RG Self-Tapping OR
- ii. As a stand-alone procedure for HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping (not HEALICOIL Knotless RG NST
- Has a pre-operative MRI collected within 6 months of surgery which meets one of the following criteria:
- MRI collected as standard-of-care has been submitted to external imaging vendor and confirmed as acceptable OR
- If standard-of-care images are unavailable or considered unacceptable by external imaging vendor, subject must undergo an additional study-specific pre- operative MRI, confirmed as acceptable by external imaging vendor OR
- MRI not required; subject not in HEALICOIL Knotless RG NST subgroup
- Has consented to participate in the study by signing the IRB/IEC approved informed consent form.
- Requires only one variant of the HEALICOIL Knotless Suture Anchor
- Is ≥18 years of age at time of surgery
- Willing and able to make all required study visits
- Able to follow instructions (Approved translated documents supplied upon request)
Exclusion Criteria
Any one (1) of the following criteria will disqualify a potential subject from participation in the study:
- Known hypersensitivity to the implant material. Where material sensitivity is suspected, appropriate tests should be made and sensitivity ruled out prior to implantation.
- Pathological conditions of bone, such as cystic changes or severe osteopenia, which would compromise secure anchor fixation.
- Pathological conditions in the soft tissues to be attached that would impair secure fixation by suture.
- Comminuted bone surface, which would compromise secure anchor fixation.
- Physical conditions which would eliminate, or tend to eliminate, adequate anchor support or retard healing
- The presence of infection.
- Conditions which would limit the subject's ability or willingness to restrict activities or follow directions during the healing period.
- Concurrent bilateral surgery.
- Participation in the treatment period of another clinical trial within thirty (30) days of Visit 1, or during the study.
- Women who are pregnant.
- Prior ipsilateral surgeries performed on the joint space.
- Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.
Data sourced from ClinicalTrials.gov (NCT04552119). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.